Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

176.06 -4.81 (-2.66%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Moderna Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union
From Moderna, Inc.
Via Business Wire
Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Why The Relaxation In Lockdowns Is Expected To Drive The Demand For COVID-19 Diagnostics Market
Via FinancialNewsMedia
Exposures COVID-19
UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility
From Moderna, Inc.
Via Business Wire
Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands
From Moderna, Inc.
Via Business Wire
Moderna Announces Agreement with Thermo Fisher Scientific for Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Moderna Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for the Moderna COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Moderna to Present at Upcoming Investor Conferences in June 2021
From Moderna, Inc.
Via Business Wire
Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Fourth Annual Science Day
From Moderna, Inc.
Via Business Wire
Moderna Announces TeenCOVE Study of its COVID-19 Vaccine in Adolescents Meets Primary Endpoint and Plans to Submit Data to Regulators in Early June
From Moderna, Inc.
Via Business Wire
Moderna and Aldevron Announce Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline
From Moderna, Inc.
Via Business Wire
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Moderna and South Korea Explore Collaboration on mRNA Vaccines
From Moderna, Inc.
Via Business Wire
Ministry of Food and Drug Safety of South Korea (MFDS) Authorizes Moderna’s COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Japan’s Ministry of Health, Labour and Welfare (MHLW) Approves Moderna’s COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Moderna to Host Fourth Annual Science Day on May 27, 2021
From Moderna, Inc.
Via Business Wire
Moderna to Establish an International Business Services Hub in Warsaw, Poland
From Moderna, Inc.
Via Business Wire
Moderna Announces New Supply Agreement with Australia for 25 Million Doses of its COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Moderna to Present at the Bank of America 2021 Healthcare Conference
From Moderna, Inc.
Via Business Wire
Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
From Moderna, Inc.
Via Business Wire
Moderna Announces New Supply Agreement with Switzerland for 7 Million Booster Vaccine Doses in 2022 and Option for Additional 7 Million Doses
From Moderna, Inc.
Via Business Wire
Moderna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants of Concern
From Moderna, Inc.
Via Business Wire
Moderna Announces Expansion of its Manufacturing Technology Center in Massachusetts
From Moderna, Inc.
Via Business Wire
Moderna Announces Supply Agreement with Gavi for up to 500 Million Doses of COVID-19 Vaccine Moderna for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries
From Moderna, Inc.
Via Business Wire
Moderna Announces Emergency Use Listing Granted by the World Health Organization for its COVID-19 Vaccine
From Moderna, Inc.
Via Business Wire
Moderna Announces Additional Investments to Increase Global Supply for COVID-19 Vaccine to up to 3 Billion Doses in 2022
From Moderna, Inc.
Via Business Wire
Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.
From Moderna, Inc.
Via Business Wire
Moderna Announces New Supply Agreement with Israel for 2022
From Moderna, Inc.
Via Business Wire
Moderna to Report First Quarter Financial Results on Thursday, May 6, 2021
From Moderna, Inc.
Via Business Wire
Moderna Announces Clinical Progress from its Industry-Leading mRNA Vaccine Franchise and Continues Investments to Accelerate Pipeline Development
From Moderna, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.